Concordance of amyloid PET and CSF metabolic biomarkers in Alzheimer's disease and how to improve it: data from the Czech Brain Ageing Study

被引：0
|
作者：
Cerman, J.
Laczo, J. [1 ,2 ]
Vyhnalek, M. [1 ,2 ]
Belohlavek, O. [3 ,4 ]
Malinovska, J. [1 ,2 ]
Sheardova, K. [5 ]
Hort, J. [1 ,2 ]
机构：
[1] Charles Univ Prague, Fac Med 2, Dept Neurol, Prague, Czech Republic
[2] Motol Univ Hosp, Prague, Czech Republic
[3] Na Homolce Hosp, Dept Nucl Med, Brno, Czech Republic
[4] Na Homolce Hosp, PET Ctr, Brno, Czech Republic
[5] St Annes Univ Hosp, ICRC, Neurol Dept 1, Brno, Czech Republic
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR1002
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [41] CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
    Hansson, Oskar
    Seibyl, John
    Stomrud, Erik
    Zetterberg, Henrik
    Trojanowski, John Q.
    Bittner, Tobias
    Lifke, Valeria
    Corradini, Veronika
    Eichenlaub, Udo
    Batrla, Richard
    Buck, Katharina
    Zink, Katharina
    Rabe, Christina
    Blennow, Kaj
    Shaw, Leslie M.
    ALZHEIMERS & DEMENTIA, 2018, 14 (11) : 1470 - 1481
  • [42] Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
    Keshavan, Ashvini
    Wellington, Henrietta
    Chen, Zhongbo
    Khatun, Ayesha
    Chapman, Miles
    Hart, Melanie
    Cash, David M.
    Coath, William
    Parker, Thomas D.
    Buchanan, Sarah M.
    Keuss, Sarah E.
    Harris, Matthew J.
    Murray-Smith, Heidi
    Heslegrave, Amanda
    Fox, Nick C.
    Zetterberg, Henrik
    Schott, Jonathan M.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [43] Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
    Keshavan, Ashvini
    Wellington, Henrietta
    Chen, Zhongbo
    Khatun, Ayesha
    Chapman, Miles
    Hart, Melanie
    Cash, David M.
    Coath, William
    Parker, Thomas D.
    Buchanan, Sarah M.
    Keuss, Sarah E.
    Harris, Matthew J.
    Murray-Smith, Heidi
    Heslegrave, Amanda
    Fox, Nick C.
    Zetterberg, Henrik
    Schott, Jonathan M.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [44] Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and β-amyloid metabolism in Alzheimer's disease
    Andreasen, N
    Gottfries, J
    Vanmechelen, E
    Vanderstichele, H
    Davidsson, P
    Blennow, K
    Rosengren, L
    Blennow, K
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (04): : 557 - 558
  • [45] Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis
    Jose Contador
    Ana Magdalena Vargas-Martínez
    Raquel Sánchez-Valle
    Marta Trapero-Bertran
    Albert Lladó
    European Archives of Psychiatry and Clinical Neuroscience, 2023, 273 : 243 - 252
  • [46] Cost-effectiveness of Alzheimer's disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis
    Contador, Jose
    Vargas-Martinez, Ana Magdalena
    Sanchez-Valle, Raquel
    Trapero-Bertran, Marta
    Llado, Albert
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2023, 273 (01) : 243 - 252
  • [47] Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology
    Kang, Ju Hee
    Korecka, Magdalena
    Lee, Edward B.
    Cousins, Katheryn A. Q.
    Tropea, Thomas F.
    Chen-Plotkin, Alice A.
    Irwin, David J.
    Wolk, David
    Brylska, Magdalena
    Wan, Yang
    Shaw, Leslie M.
    CLINICAL CHEMISTRY, 2023, 69 (11) : 1247 - 1259
  • [48] Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
    Tharick A. Pascoal
    Sulantha Mathotaarachchi
    Monica Shin
    Ah Yeon Park
    Sara Mohades
    Andrea L. Benedet
    Min Su Kang
    Gassan Massarweh
    Jean-Paul Soucy
    Serge Gauthier
    Pedro Rosa-Neto
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1021 - 1030
  • [49] Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease
    Pascoal, Tharick A.
    Mathotaarachchi, Sulantha
    Shin, Monica
    Park, Ah Yeon
    Mohades, Sara
    Benedet, Andrea L.
    Kang, Min Su
    Massarweh, Gassan
    Soucy, Jean-Paul
    Gauthier, Serge
    Rosa-Neto, Pedro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (06) : 1021 - 1030
  • [50] Asymmetric amyloid deposition in preclinical Alzheimer's disease: A PET study
    Kjeldsen, Pernille L.
    Parbo, Peter
    Hansen, Kim, V
    Aanerud, Joel F. A.
    Ismail, Rola
    Nissen, Peter H.
    Dalby, Rikke B.
    Damholdt, Malene F.
    Borghammer, Per
    Brooks, David J.
    AGING BRAIN, 2022, 2
12345